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Abstract
Background: Although Staphylococcus aureus is considered the main etiological agent of infectious
mastitis, recent studies have suggested that coagulase-negative staphylococci (CNS) may also play
an important role in such infections. The aims of this work were to isolate staphylococci from milk
of women with lactational mastitis, to select and characterize the CNS isolates, and to compare
such properties with those displayed by CNS strains isolated from milk of healthy women.
Results: The milk of 30 women was collected and bacterial growth was noted in 27 of them, of
which Staphylococcus epidermidis was isolated from 26 patients and S. aureus from 8. Among the 270
staphylococcal isolates recovered from milk of women with mastitis, 200 were identified as
Staphylococcus epidermidis by phenotypic assays, species-specific PCR and PCR sequencing. They
were typified by pulsed field gel electrophoresis (PFGE) genotyping. The PFGE profiles of the S.
epidermidis strains were compared with those of 105 isolates from milk of healthy women. A
representative of the 76 different PFGE profiles was selected to study the incidence of virulence
factors and antibiotic resistance. The number of strains that contained the biofilm-related icaD gene
and that showed resistance to oxacillin, erythromycin, clindamycin and mupirocin was significantly
higher among the strains isolated from mastitic milk.
Conclusion: S. epidermidis may be a frequent but largely underrated cause of infectious mastitis in
lactating women. The resistance to diverse antibiotics and a higher ability to form biofilms found
among the strains isolated from milk of women suffering mastitis may explain the chronic and/or
recurrent nature of this infectious condition.
Background
Mastitis is a common condition during lactation and its
incidence oscillates between 5 and 33% of the lactating
mothers [1,2]. The number of non-infectious mastitis that
become an infectious disease is usually so high that some
authors define the term "mastitis" as an infectious process
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of the mammary gland characterized by a variety of local
and systemic symptoms [3]. However, the number of
studies dealing with the microbiological aspects of human
mastitis is low and the role of specific agents has yet to be
described. In fact, published articles on the bacteria caus-
ing this condition are scarce and most are, at least, 10
years old [2].
Traditionally, Staphylococcus aureus has been considered
the most common etiological agent although, unfortu-
nately, the cases in which microbiological analyses are
performed are exceptional. However, treatments with
antibiotic or antifungal drugs are usually prescribed with-
out knowing the etiology or the antibiotic susceptibility of
the microorganism involved. This practice may lead to a
worsening of the symptoms since strains that cause masti-
tis may exhibit multirresistance to drugs and/or form bio-
films. Therefore, a better knowledge of the main features
of the bacterial species involved in the mastitic process
would represent a great advance for the design of new
strategies for the prevention and/or treatment of this con-
dition.
In a previous work, we investigated the microbial diversity
of breast milk in 20 women with lactational mastitis by
culture-dependent and -independent techniques [4], and
observed that staphylococci, mainly Staphylococcus epider-
midis, seem to be the major microorganisms present in
breast milk of women with infectious mastitis. In recent
years S. epidermidis has become increasingly recognized as
opportunistic pathogen [5,6]. Parallel, several genetic
determinants involved in mechanisms of adhesion and
biofilm formation have been described in this species
[7,8] while its rate of resistance to several antibiotics has
increased during the last years [9-11].
In this context, the objective of the present study was to
evaluate the presence of S. epidermidis in breast milk of
women with infectious mastitis, to characterize the iso-
lates and to compare their properties with those of strains
isolated from milk of healthy women.
Results
Bacterial counts and identification of staphylococci in milk
Presence of staphylococci was observed in 27 of the 30
samples provided by women with lactational mastitis. In
these samples, counts in Baird Parker (BP) agar plates
ranged between 4.0 and 6.0 log10 cfu mL-1 (Table 1). A
total of 270 isolates were obtained from the BP plates (10
from each woman) and all of them were lysozyme-resist-
ant, lysostaphin-sensitive, catalase-positive, Gram-posi-
tive cocci. Among these presumptive staphylococcal
isolates, 200 were identified as S. epidermidis on the basis
of biochemical tests and species-specific PCR assays. This
species was present in 26 milk samples. Only 35 staphylo-
coccal isolates belonged to the species S. aureus and they
were obtained from milk of eight women. PCR sequenc-
ing of a 16S rDNA fragment confirmed the results. The
remaining 35 isolates that gave no amplification with the
multiplex PCR were further identified by 16S rDNA PCR
sequencing as Staphylococcus pasteuri (n = 16), Staphylococ-
cus warneri (n = 11) and Staphylococcus hominis (n = 8)
(Table 1). The partial 16S rDNA sequences obtained from
single isolates belonging to the species Staphylococcus
aureus and Staphylococcus epidermidis were deposited in the
EMBL nucleotide sequence database under accession
numbers [EMBL: AM697666] and [EMBL: AM697667],
respectively. Then, our attention was focused on the S. epi-
dermidis isolates.
Genotyping of the S. epidermidis isolates by PFGE 
profiling
The 200 isolates of S. epidermidis recovered in this study
were subjected to PFGE genotyping together with 105 iso-
lates previously obtained from breast milk of 12 healthy
women (Table 1). The analysis of the fingerprints
obtained revealed the existence of 40 different pulsotypes
among the isolates from women with mastitis and 36
among healthy women. Comparison of these genotypes
showed that most of the strains grouped together depend-
ing on their origin in two different clusters, one contain-
ing most of the strains obtained from mastitic milk while
the second contained most of the strains isolated from
milk of healthy women (Figure 1).
Detection of virulence determinants among the S. 
epidermidis strains
The 76 different S. epidermidis strains (40 from milk of
women with mastitis and 36 strains from that of healthy
women) were selected to study the presence of potential
virulence traits. Hemolytic activity could not be detected
or was very weak among all the assayed strains. In relation
to adhesion-related genes, the multiplex PCR assay
revealed the presence of the genes embp and atlE in all the
strains. The fbe gene was detected in 65% of the strains
from mastitis and in 75% of those isolated from healthy
women (P = 0,3434). In contrast, the icaD gene was more
prevalent among strains from mastitis cases (33%) than in
those from healthy women (11%) (P = 0,0255) (Figure
1). A good correlation was observed between the presence
of biofilm-related ica  operon and the results obtained
using the CRA assay, which determines potential for slime
production, and all the strains that amplified for the gene
gave also positive results by the phenotypic assay.
Determination of MIC's to several antibiotics
Determination of MIC's to 21 antibiotics or antibiotics
mixtures in the 76 S. epidermidis strains revealed that all of
them were susceptible to the lower concentration of nitro-
furantoin (32 μg mL-1) and rifampin (1 μg mL-1) while theBMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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Table 1: Samples and isolates used in this study
Milk sample Staphylococcal concentration (log10 cfu mL-1 ± 
SD; n = 3)
Identified species 
(number of isolates)
Number of PFGE profiles (S. 
epidermidis)
Characterized S. epidermidis 
strains
A. Women with mastitis
1 5.28 ± 0.05 S. epidermidis (5) S. aureus (5) 1 C213
2 4.78 ± 0.32 S. epidermidis (10) 3 CJBP1
CJBP2
CJBP3
3N d - - -
4N d - - -
5 4.91 ± 0.29 S. epidermidis (8)
S. aureus (1)
S. pasteuri (1)
1B
6 4.41 ± 0.17 S. epidermidis (7) S. hominis (3) 1 K
7 4.04 ± 0.09 S. epidermidis (7)
S. aureus (3)
2C J 9
CJ11
8 4.91 ± 0.50 S. epidermidis (10) 3 S1LDC12
S1LDC13
S1LDC18
9 4.72 ± 0.44 S. epidermidis (2)
S. pasteuri (4)
S. hominis (4)
1F 1 2
10 4.23 ± 0.47 S. epidermidis (10) 1 DC2Lae
11 4.38 ± 0.22 S. epidermidis (6) S. aureus (4) 1 B1CD2
12 4.08 ± 0.51 S. epidermidis (10) 1 DD2Laa
13 Nd - - -
14 4.25 ± 0.08 S. epidermidis (5)
S. aureus (5)
1 PLD21
15 4.41 ± 0.15 S. epidermidis (10) 1 P2LD1
16 4.51 ± 0.12 S. epidermidis (6)
S. warneri (4)
1 M121
17 4.52 ± 0.04 S. epidermidis (7)
S. pasteuri (3)
1D F 2 L a b
18 4.80 ± 0.53 S. epidermidis (8)
S. warneri (2)
1V 1 L D 1
19 5.68 ± 0.22 S. epidermidis (8)
S. pasteuri (2)
1D H 3 L I k
20 4.48 ± 0.33 S. epidermidis (9)
S. hominis (1)
2D G 2 ñ
DG2s
21 4.04 ± 0.12 S. epidermidis (5) S. warneri (5) 1 YGLI4
22 4.17 ± 0.06 S. epidermidis (7) S. aureus (3) 1 ASLI3
23 5.44 ± 0.09 S. epidermidis (10) 3 ASLD1
ASLD2
ASLD3BMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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24 4.15 ± 0.45 S. epidermidis (7)
S. pasteuri (3)
1A R L I 1
25 4.64 ± 0.14 S. epidermidis (10) 4 Z2LDC11
Z2LDC12
Z2LDC14
Z2LDC17
26 4.02 ± 0.22 S. epidermidis (10) 1 AQLI2
27 4.05 ± 0.07 S. epidermidis (6)
S. aureus (4)
1A Q L D 3
28 4.04 ± 0.03 S. aureus (10) - -
29 4.09 ± 0.09 S. epidermidis (7)
S. pasteuri (3)
1 AEA1
30 4.05 ± 0.24 S. epidermidis (10) 4 YLIC13
YLIC14
YLIC16
YLIC17
B. Healthy women
1 2.91 ± 0.27 S. epidermidis (5)
S. aureus (4)
S. lugdunensis (1)
5 LC016
LC017
LC019
LC044
LC047
2 2.41 ± 0.09 S. epidermidis (10) 3 LE010
LE011
LE035
3 2.04 ± 0.11 S. epidermidis (10) 5 LG005
LG006
LG5021
LG5022
LG5023
4 1.91 ± 0.12 S. epidermidis (10) 2 LP22
LP223
5 2.02 ± 0.29 S. epidermidis (8)
S. hominis (2)
3L V 2 2 1
LV222
LV521
6 2.93 ± 0.21 S. epidermidis (10) 3 LX5RB3
LX5RB4
LX5081
7 2.38 ± 0.14 S. epidermidis (4)
S. aureus (4)
S. hominis (2)
3 LO5081
LO5082
LO5RB1
8 2.58 ± 0.31 S. epidermidis (10) 3 LCC5081
LCC5082
LCC0592
9 2.48 ± 0.07 S. epidermidis (8)
S. aureus (2)
4 LI5081
LI5094
LIRB1
LIRB2
10 2.25 ± 0.10 S. epidermidis (10) 2 LV5081
LV5RB3
11 2.41 ± 0.12 S. epidermidis (10) 2 LG5082a
LGRB1
12 2.51 ± 0.22 S. epidermidis (10) 1 24C13
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Dendogram obtained by PFGE analysis of the S. epidermidis strains from mastitis and healthy women Figure 1
Dendogram obtained by PFGE analysis of the S. epidermidis strains from mastitis and healthy women. Strains 
isolated from mastitis-suffering women are shaded. Information on the presence of icaD, fbe and mecA genes and resistance to 
oxacillin (OXA; MIC > 2 μg mL-1), erythromycin (ERY; MIC > 4 μg mL-1), clindamycin (CLY; MIC > 2 μg mL-1) and mupirocin 
(MUP; MIC > 512 μg mL-1) has been included.
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Table 2: Distribution of MIC's to several antibiotics among S. epidermidis isolated from mastitis and healthy women
Percentage of strains for which the MIC (μg mL-1) was as follows:
Antibiotics Breast milk N° of strains ≤ 0.03 0.12 0.25 0.5 1 2 4 8 > 8
PEN H 36 17 8 8 14 14 8 11 19
M 40 10 5 5 8 10 33 8 8 18
AMP ≤ 0.12 0.25 0.5 1 2 4 8 100 > 100
H3 6 1 9 6 1 7 2 2 8 8 6 1 4
M4 0 1 5 8 5 2 3 2 0 1 0 5 1 3 3
OXA ≤ 0.25 0.5 1 2 > 2
H3 6 1 1 3 1 1 1 8 39
M4 0 5 8 1 3 8 68
CIP ≤ 0.25 0.5 1 2 > 2
H3 6 4 7 3 9 8 6
M4 0 3 0 3 8 1 8 3 1 3
CHL ≤ 81 6 >  1 6
H3 6 7 5 1 7 8
M4 0 7 8 1 0 1 3
ERY ≤ 0.25 0.5 1 2 4 > 4
H3 6 3 9 1 4 6 8 33
M4 0 2 3 1 5 3 60
CLI ≤ 0.5 1 2 > 2
H3 6 8 1 8 3 8
M4 0 7 0 3 28
TET ≤ 48 >  8
H3 6 5 6 1 9 2 5
M4 0 6 8 8 2 5
VAN ≤ 0.5 1 2 4 8 16 ≥ 16
H3 6 4 4 5 0 6
M4 0 4 3 4 8 5 3 3
MUP ≤ 42 5 6>  2 5 6
H3 6 7 8 1 1 11
M4 0 5 8 1 3 30
H: strains isolated from healthy women; M: strains isolated from mastitis-suffering women; PEN: penicillin; AMP: ampicillin; OXA: oxacillin; CIP: 
ciprofloxacin; CHL: chloramphenicol; ERY: erythromycin; CLI: clindamycin; TET: tetracycline; VAN: vancomycin; MUP: mupirocin.
Statistically-significant differences between isolates from mastitis and healthy women are in bold.BMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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results against the rest of antibiotics were variable depend-
ing on the strains (Table 2). Independently of their origin,
most of the strains were sensitive to trimethoprim/sulfam-
ethoxazole (MIC < 2/38 μg mL-1 for 90% of the strains),
gentamicyn (≤ 2 μg mL-1 for 87%), linezolid (≤ 2 μg mL-
1 for 86%), fosfomicyn (≤ 16 μg mL-1 for 82%), cipro-
floxacin (≤ 0,5 μg mL-1 for 76%), tetracycline (≤ 8 μg mL-
1 for 75%), chloramphenicol (≤ 16 μg mL-1 for 90%), pen-
icillin (≤ 4 μg mL-1 for 72%), ampicillin (≤ 4 μg mL-1 for
80%) and the glycopeptides vancomycin (≤ 2 μg mL-1 for
93%) and teicoplanin (≤ 1 μg mL-1 for 70%). The percent-
age of susceptible strains was lower for imipenem (≤ 0,12
μg mL-1for 58%) and quinupristin/dalfopriscin (≤ 0,25 μg
mL-1  for 57%). However, significant differences were
observed in the percentage of strains resistant to some
antibiotics depending on their origin (Figure 1). For
instance, 43% of isolates from mastitic samples showed a
MIC of mupirocin ≥ 512 μg mL-1 while only 22% of those
isolated from non-mastitic samples reached this value (P
= 0,0437). Similarly, 60% of the mastitic-related strains
showed a MIC > 4 μg mL-1 against erythromycin in con-
trast to 33% of the other group (P = 0,0201). In the case
of clindamycin, 28% of the strains from mastitic milk pre-
sented a MIC > 2 μg mL-1 while the percentage was of 8%
in strains from healthy women (P = 0,0314). A higher per-
centage of oxacillin resistance (MIC > 2 μg mL-1) was also
found among the strains from mastitis (68%) than those
from healthy mothers (39%) (P = 0,0125). Finally, two
strains from women with mastitis (CJ11 and DG2S) were
resistant to streptomycin (> 1000 μg mL-1) and one strain
(AQLI2) from the same group was resistant to vancomy-
cin (16 μg mL-1). No strains resistant to these two antibi-
otics were found among the strains from healthy women.
Presence of mecA and SCCmec typing
Among the 41 strains showing oxacillin resistance, the
mecA gene could be detected by PCR in 37 (25 from mas-
titic milk and 12 from milk of healthy women). No ampli-
fication was observed in two strains of each group (F12
and CJ9; LI5081 and LC047, respectively), which had
shown an oxacillin MIC value of > 2 μg mL-1. In contrast,
the mecA gene was detected in five oxacillin susceptible
strains, one from a mastitis case (YLIC13) and four from
healthy women (LO5RB1, LX5RB3, LV221 and LCC
5082).
The type of SCCmec  was determined in all the mecA+
strains. The ccrB gene could be amplified from 22 of the
26 mecA+ strains from the mastitis group and, on the basis
of the ccrB restriction pattern with HinfI (type IV: 264, 227
and 154 bp; type III: 537 and 106 bp) or with HinfI/BsmI
(type IV: 227, 171, 153 and 93 bp; type III: 320, 174, 106
and 44 bp), 19 strains were assigned to type IV and the
remaining three (S1LDC12, Z2LDC17 and DF2LAB) to
type III (see additional file 1). Amplification of ccrB was
achieved in the 16 mecA+ strains from healthy women
and, among them, 14 strains showed type IV and two type
III SCCmec. The application of the full assay described by
Zhang et al. [12] confirmed these results. The 4 mecA+
strains that could not be typed on the basis of their ccrB
restriction pattern remained non typeable with the full
Zhang et al. assay.
Discussion
S. epidermidis is a normal inhabitant of the skin and
mucosal surfaces in healthy hosts and its ubiquitous prev-
alence as a commensal species makes difficult for a clini-
cian to decide if an isolate represents the etiological agent
or a culture contamination [11]. Therefore, isolation of
this bacterial species is generally regarded as non-related
to a mastitis case, even when it is the only species present
in a milk sample [4].
S. epidermidis was the dominant or unique staphylococcal
species in breast milk of women suffering mastitis, a find-
ing described previously [4], which indicates that this bac-
terial species could be an etiological agent of human
lactational mastitis. Similarly, several studies have shown
the implication of this bacterial species as an agent of
mastitis in different animal species [13-15].
The genotyping of the S. epidermidis isolates by PFGE
revealed a low diversity within this species in the breast
milk of women with mastitis, with a mean of 2 different
profiles per sample. A lost in the microbial diversity
present in milk of women with mastitis has been previ-
ously pointed [4]. Comparison by PFGE dendogram anal-
ysis of these strains with those obtained from breast milk
of healthy women showed the existence of two main clus-
ters and, within these two groups, the strains generally
matched with the origin (mastitis and healthy women).
However, a few strains from healthy women grouped
together with the mastitis cluster reflecting a similar
genetic background. The fact that their presence in milk of
healthy women does not constitute a health problem
could indicate that a predisposal host is also need for S.
epidermidis to develop an infection [16].
Among the S. epidermidis strains analyzed, the presence of
adhesion-related genes was high independently of the
condition of the women from which they were isolated.
The presence of genes encoding cell surface proteins may
explain, at least partially, the high prevalence of S. epider-
midis in breast milk, mammary areola and ducts of both
healthy and mastitis-suffering women. In contrast, the
percentage of strains carrying the biofilm-related ica
operon was higher in strains from mastitis milk than in
that obtained from healthy women. A potential relation-
ship between S. epidermidis infection and the presence of
such operon has been reported [8]. In fact, biofilm forma-BMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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tion has been described in many cases of staphylococcal
mastitis and this is the reason why such property is con-
sidered as a potential virulence factor [17,18].
Strains belonging to either the mastitis or the healthy
women group showed a similar susceptibility against
many of the antibiotics tested; however, a higher percent-
age of mupirocin-, erythromycin-, clindamicyn- and oxa-
cillin-resistant strains was found among those isolated
from mastitic milk. Resistance to these and other antibiot-
ics in pathogenic S. epidermidis isolates has been reported
previously [10,19]. The resistance of these strains could be
partly due to the increasing use of broad-spectrum antibi-
otics, which encourage selection of multirresistant strains
[11]. Improper antibiotherapy may explain why staphylo-
coccal mastitis frequently becomes a chronic and/or recur-
rent infection. In this study, the presence of mecA gene
accompanied with resistance to oxacillin (MIC > 2 μg mL-
1) was observed in 62% of the strains from mastitis, but
only in 33% from the healthy group. The mecA gene was
not detected in four oxacillin-resistant strains. These
strains may represent cases of borderline resistance which
is characterized by an oxacillin MIC at or just above the
susceptibly breakpoint (4 to 8 μg mL-1). In contrast, the
mecA gene was detected in five oxacillin-susceptible
strains, a fact that has been previously described [20] and
that may be due to gene deletions.
Methicillin-resistant  Staphylococcus aureus (MRSA) are
being reported with increasing frequency in the commu-
nity and they have been called community-acquired (CA)-
MRSA, which are associated with skin and soft tissue
infection [21] but are also frequently isolated from
healthy hosts [22]. Most of the mecA+ strains used in this
study could be ascribed to type IV SCCmec. In S. epider-
midis, some studies have reported that SCCmec type IV is
generally carried by CA-MRS [23,24] but this type seems
to be predominant among clinically relevant S. epidermidis
isolates [9]. The fact that the ccrB gene was not amplified
from four mecA+ strains may be due to the presence of dif-
ferent alleles for this gene [25].
In the last years, a renewed medical and research interest
has been focused on S. epidermidis since it has become the
most important cause of nosocomial infections [6]. The
complete genome analysis of some methicillin-resistant S.
aureus and S. epidermidis strains of human origin have
revealed the propensity of S. aureus to cause fulminant
and sometimes life-threatening infections, as opposed to
the predisposition of S. epidermidis for chronic and recur-
rent infections [26]. Identification of S. epidermidis as eti-
ological agents of infection is sometimes hindered by the
fact that infections associated with this microorganims are
characterized by subtle, non-specific clinical manifesta-
tions [5]. Precisely, these characteristics occur in most
cases of lactational mastitis. Genome flexibility in S. epi-
dermidis may contribute to the acquisition of some trans-
ferable virulence and resistant traits [6,27] and to the
evolution of this species from a commensal to a patho-
genic microorganism in susceptible hosts [28]. In fact, it
seems that there is an important host factor in lactational
mastitis since a woman having such condition usually dis-
plays the same clinical signs after subsequent pregnancies.
Additionally, it would explain why only a 3–30% of lac-
tating women suffer from such infection when it is the
predominant bacterial species found in breast milk of
healthy women [29,30].
Conclusion
Staphylococcus epidermidis is the most prevalent staphylo-
coccal species isolated from breast milk of women suffer-
ing mastitis, where it is present at a concentration notably
higher than that present in milk of healthy woman (≥ 4.0
versus ≤ 3.0 log10 cfu mL-1, respectively). The percentage of
strains showing biofilm production ability and resitance
to mupirocin, erythromycin, clindamicyn and/or methi-
cillin was significantly higher among those obtained from
women with lactational mastitis than among those iso-
lated from healthy women.
The random method used to select staphylococcal colo-
nies from the samples could introduce a bias regarding the
low number of samples from which S. aureus was isolated.
Traditionally, S. aureus has been considered as the main
etiological agent of mastitis. However, the results of this
work suggest that S. epidermidis could be an additional
and underrated cause of lactational mastitis; as a conse-
quence, its presence should be also considered in bacteri-
ological analyses of human milk when there is a
suspicious of a mastitis infection. Further studies involv-
ing a larger number of samples and staphylococcal iso-
lates will be required to confirm the results obtained in
this study.
Methods
Samples and isolation of staphylococcal isolates
A total of 30 women aged 25–34 years with clinical symp-
toms of infectious mastitis participated in the study (Table
1). They were diagnosed by the lactation consultants
attending different primary health-care centers in Spain in
a 2-months period (October-November 2007). The total
staphylococcal count was higher ≥ 4 log10 cfu mL-1 in all
their samples. Women with mammary abscesses or any
kind of parallel diseases and patients treated with antibi-
otherapy during the previous two weeks of the study were
excluded. All volunteers gave written informed consent to
the protocol, which was approved by the Ethical Commit-
tee of Hospital Clínico of Madrid (Spain). The milk sam-
ples were collected as described previously [31], and
plated onto ready to use Baird Parker (BP) plates suppliedBMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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by bioMérieux (Marcy l'Etoile, France). The plates were
incubated in aerobiosis at 37°C for 48 h.
Identification of staphylococci
Initially, a total of 270 isolates (10 from each sample dis-
playing bacterial growth on BP plates) were randomly
selected and tested for catalase and coagulase activities
and for their resistance to lysozyme and lysostaphin [32].
All of them were subjected to a novel multiplex PCR
method designed to allow a rapid identification of S. epi-
dermidis  and  S. aureus isolates. The new primers (see
below) were designed on the basis of the variable regions
of the tuf gene sequence of Staphylococcus using the pro-
gram Clone Manager Suite 7.0 (Sci Ed Central, USA).
Their specificity was tested in silico by PCR simulation
against up-to-date sequenced prokaryotic genomes using
the tools provided in the website http://insilico.ehu.es/
PCR. Briefly, a colony of each isolate was suspended in 20
μL of TE buffer (10 M Tris-HCl, 1 M EDTA pH 8) with
0.9% NaCl, and after heating at 98°C for 10 min, the sus-
pension (5 μL) was used as a template for PCR using the
BioredMix (BioLine, London, UK) system and the primers
(10 μM) tuf-g (5'-GGTGTACCAGCATTAGT-3'), tuf-a (5'-
TTCAGTATGTGGTGTAA-3') and tuf-e (5'-TTCGTGCAT-
ACCGATGA-3'). The primer pairs tuf-g/tuf-e and tuf-g/tuf-
a result in a 370 bp (S. epidermidis) or a 530 bp (S. aureus)
fragment [see additional file 2]. PCR conditions were 1
cycle of 94°C for 5 min, 30 cycles of 94°C for 1 min, 48°C
for 1 min, and 72°C for 2 min, and a final extension of
72°C for 5 min. Identification of the isolates was con-
firmed by PCR sequencing of a 470 bp fragment of the 16S
rRNA gene using primers and conditions previously
described [33]. The amplicons were purified using the
Nucleospin® Extract II kit (Macherey-Nagel, Düren, Ger-
many) and sequenced at the Genomics Unit of the Uni-
versidad Complutense de Madrid, Spain.
Genotyping of S. epidermidis isolates by pulsed field gel 
electrophoresis (PFGE)
To determine the diversity of S. epidermidis in breast milk
in mastitis infections, 200 isolates of this species obtained
from 26 women with mastitis were subjected to PFGE
genotyping together with 105 isolates of the same species
obtained from breast milk of 12 healthy women within
the same period of time [34] (Table 1). Chromosomal
DNA was digested with the endonuclease SmaI (New Eng-
land Biolabs, Ipswich, MA) at 37°C for 16 h. Electro-
phoresis was carried out in a CHEF DR-III apparatus (Bio-
Rad Laboratories, Hercules, CA) for 23 h at 14°C at 6 V
cm-1  with pulses from 5 to 50 s. A standard pattern
(Lamda Ladder PFG Marker, New England Biolabs) was
included in the gels to allow comparison of the digitally
normalized PFGE profiles. Computer-assisted analysis of
the gels was performed with the Phoretix 1D Pro software
(Nonlinear USA, Inc., Durham, NC). PFGE profiles differ-
ing in one or more fragments were considered different.
Cluster analysis of the PFGE patterns was performed using
the UPGMA method based on the Dice similarity coeffi-
cient.
Screening for potential virulence determinants
On the basis of the different PFGE profiles, 76 strains (40
from mastitis cases and 36 from healthy women) were
further selected and characterized. Presence of genes embp,
fbe, atlE and icaD, which respective products are involved
in adhesion and biofilm formation, was evaluated using
primers couples described previously [7,35-37]. In the
case of fbe, atlE and icaD, a multiplex PCR format was
designed using the following conditions: 5 min at 94°C
followed by 30 cycles of 94°C for 1 min, 60°C for 30 s,
72°C for 1 min and, then, a final extension of 5 min at
72°C [see additional file 3]. Strains isolated from mastitic
milk were compared to those isolated from healthy
women. Data were subjected to a statistical analysis using
the Chi-square test (SPSS package, SPSS Inc, Chicago, IL,
USA). Differences were considered significant if P values
were lower than 0.05.
Phenotypic assays
The hemolytic activity of the isolates was determined on
Columbia agar supplemented with 5% horse blood
(COH, bioMériux) after incubation at 37°C for 72 h fol-
lowing a procedure previously described [32]. The ability
of the isolates to form slime was assessed using the Congo
Red agar assay (CRA) [38]. The plates were incubated at
37°C for 24 h and, then, for additional 24 h at room tem-
perature.
Determination of MIC's to antibiotics
The determination of the MIC's to several antibiotics com-
monly used against staphylococcal infections was evalu-
ated by a microdilution method using the Sensititre plates
Staenc1F (Trek Diagnostic Systems, Cleveland, OH) fol-
lowing the manufacturer's instructions. The antibiotics
analyzed were: penicillin, ampicillin, amoxycillin-clavu-
lanic acid, teicoplanin, chloramphenicol, erythromycin,
mupirocin, streptomycin, gentamicin, clindamycin, oxa-
cillin, ciprofloxacin, fosfomycin, imipenem, nitrofuranto-
ine, trimethoprim-sufamethoxazole, tetracycline,
vancomycin, linezolid, quinupristin-dalfopristin and
rifampin. Data were submitted to the statistical analysis
described above.
Screening for mecA gene and typing of the staphylococcal 
chromosome cassette mec (SSCmec)
Presence of the mecA gene was evaluated by PCR using
primers mecA forward (5'-GGTCCCATTAACTCTGAAG-3')
and  mecA reverse (5'-AGTTCTGCAGTACCGGATTTTGC-
3'), which results in a 1,040 bp fragment [39]. The SCC-
mec  was subjected to a typing procedure [40], whichBMC Microbiology 2009, 9:82 http://www.biomedcentral.com/1471-2180/9/82
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implied the PCR amplification of the ccrB gene followed
by RFLP analysis using endonucleases HinfI and BsmI.
Presence of mecA and SCCmec typing was confirmed using
all the primers and conditions described by Zhang et al.
[12].
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